QUiPP vs MOXFQ

A tool to predict spontaneous preterm birth, incorporating fetal fibronectin and cervical length, in symptomatic women and high-risk asymptomatic women. This App was created by Woman’s Health Academic Centre, Kings College London and is based on a study of over 1000 women in conjunction with St. Thomas' Hospital. Quippp is designed to be used by clinicians with access to quantifiable ffn along with some Clinical details. Cervical Length is also required for asymptomatic women. This will be updated once more data becomes available. Further Information can be found at: www.quipp.org

Complete the Manchester-Oxford Foot Questionnaire (MOXFQ) and calculate scores for foot and ankle symptoms. Answer 16 questions about the past four weeks, selecting the right or left side and the assessment date. If both sides are affected, complete a separate questionnaire for each side. The app displays the overall MOXFQ-Index, walking/standing, pain and social interaction scores on a 0–100 scale, plus the raw total out of 64. Higher scores indicate greater symptoms or difficulty. All 16 questions must be answered before results appear. Responses are held only during the current app session. The app does not save or transmit questionnaire answers. The MOXFQ is a patient-reported outcome measure developed and validated for evaluating outcomes of foot and ankle surgery. The questionnaire is used under licence from Oxford University. This app provides questionnaire scores; it does not diagnose conditions or recommend treatment. Questionnaire copyright © Oxford University Innovation Limited, 2006. All rights reserved. English version for the United Kingdom. References: Dawson J et al. The MOXFQ patient-reported questionnaire: assessment of data quality, reliability and validity in relation to foot and ankle surgery. Foot. 2011;21(2):92–102. Morley D et al. The Manchester-Oxford Foot Questionnaire (MOXFQ): development and validation of a summary index score. Bone Joint Res. 2013;2:66–69.